NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Agile Therapeutics Inc (NASDAQ: AGRX)

 
AGRX Technical Analysis
5
As on 5th Aug 2022 AGRX SHARE Price closed @ 0.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.27 & Strong Sell for SHORT-TERM with Stoploss of 2.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AGRXSHARE Price

Open 0.60 Change Price %
High 0.62 1 Day -0.02 -3.23
Low 0.56 1 Week 0.08 15.38
Close 0.60 1 Month -0.60 -50.00
Volume 3552900 1 Year -2.49 -80.58
52 Week High 3.35 | 52 Week Low 0.11
 
NASDAQ USA Most Active Stocks
AMD 102.31 -1.54%
MRKR 0.54 63.64%
DKNG 17.96 9.78%
AAPL 165.35 -0.28%
OPEN 5.72 21.70%
BBBY 8.16 32.68%
AMZN 140.80 -1.24%
LYFT 20.28 16.62%
GOVX 3.22 -9.80%
ENDP 0.72 12.50%
 
NASDAQ USA Top Gainers Stocks
REDU 3.41 1075.86%
USWS 5.60 508.70%
NDRAW 0.03 200.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
GPCOR 0.15 114.29%
GSMGW 0.02 100.00%
FTVIW 0.22 83.33%
GBRGR 0.12 71.43%
PTOCW 0.17 70.00%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
CREXW 0.04 -55.56%
MILEW 0.06 -53.85%
HSDT 0.48 -52.94%
BTAQW 0.01 -50.00%
ALACW 0.01 -50.00%
HYZNW 0.37 -49.32%
ACBAW 0.08 -46.67%
ALACR 0.04 -42.86%
IKNX 19.52 -42.42%
 
 
AGRX
Daily Charts
AGRX
Intraday Charts
Whats New @
Bazaartrend
AGRX
Free Analysis
 
AGRX Important Levels Intraday
RESISTANCE0.72
RESISTANCE0.68
RESISTANCE0.66
RESISTANCE0.63
SUPPORT0.57
SUPPORT0.54
SUPPORT0.52
SUPPORT0.48
 
AGRX Forecast August 2022
4th UP Forecast2.87
3rd UP Forecast2.14
2nd UP Forecast1.69
1st UP Forecast1.24
1st DOWN Forecast-0.04
2nd DOWN Forecast-0.49
3rd DOWN Forecast-0.94
4th DOWN Forecast-1.67
 
AGRX Weekly Forecast
4th UP Forecast1.81
3rd UP Forecast1.42
2nd UP Forecast1.18
1st UP Forecast0.94
1st DOWN Forecast0.26
2nd DOWN Forecast0.02
3rd DOWN Forecast-0.22
4th DOWN Forecast-0.61
 
AGRX Forecast2022
4th UP Forecast8.81
3rd UP Forecast6.18
2nd UP Forecast4.55
1st UP Forecast2.92
1st DOWN Forecast-1.72
2nd DOWN Forecast-3.35
3rd DOWN Forecast-4.98
4th DOWN Forecast-7.61
 
 
AGRX Other Details
Segment EQ
Market Capital 95123296.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
AGRX Address
AGRX
 
AGRX Latest News
 
Your Comments and Response on Agile Therapeutics Inc
 
AGRX Business Profile
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey. Address: 101 Poor Farm Road, Princeton, NJ, United States, 08540
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service